| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1957) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | B01AA04 |
| UNII: | Q08SIO485D |
| InChI Key | QNDUUBVQYBBRBW-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H16O3 |
| Molecular Weight | 280.32 |
| AlogP | 4.04 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 50.44 |
| Molecular species | ACID |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 21.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor |
| Primary Target | |
|---|---|
| vitamin K epoxide reductase complex subunit 1 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2D
Cytochrome P450 2D6
|
- | 528000 | - | - | - | |
|
Enzyme
Oxidoreductase
|
- | - | - | 200 | - | |
|
Enzyme
Protease
Aspartic protease
Aspartic protease AA clan
Aspartic protease A2A subfamily
|
- | 1000 | - | 0.8-1000 | - | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -11.3-16.18 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Venous Thrombosis | 3 | D020246 | ClinicalTrials |
| Venous Thrombosis | 3 | D020246 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 435-97-2 |
| ChEBI | 50438 |
| ChEMBL | CHEMBL1465 |
| DrugBank | DB00946 |
| DrugCentral | 2138 |
| EPA CompTox | DTXSID5023459 |
| FDA SRS | Q08SIO485D |
| Human Metabolome Database | HMDB15081 |
| Guide to Pharmacology | 6839 |
| KEGG | D05457 |
| PubChem | 54680692 |
| SureChEMBL | SCHEMBL43031 |
| ZINC | ZINC03876174 |